Cargando…
Investigating Idiopathic Inflammatory Myopathy; Initial Cross Speciality Experience with Use of the Extended Myositis Antibody Panel
The discovery of unique autoantibodies has informed and altered our approach to the diagnosis and management of the inflammatory myopathies. This study reports the initial clinical experience of use of the Extended Myositis Antibody (EMA) panel in the largest university teaching hospital in Ireland....
Autores principales: | O'Connor, Antoinette, Mulhall, Jennifer, Harney, Sinead M.J., Ryan, John G., Murphy, Grainne, Henry, Michael T., Annis, Peter, Tormey, Vincent, Ryan, Aisling M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432941/ https://www.ncbi.nlm.nih.gov/pubmed/28567235 http://dx.doi.org/10.4081/cp.2017.922 |
Ejemplares similares
-
The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013) -
Coexistence of Multiple Myositis-Specific Antibodies in Patients with Idiopathic Inflammatory Myopathies
por: Huang, Hung-Ling, et al.
Publicado: (2022) -
Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies
por: Perron, Megan Mariko, et al.
Publicado: (2021) -
Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies
por: Mageriu, Vlad, et al.
Publicado: (2020) -
Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)